Kemantane: historical immunostimulatory-use disclosure — SU1586711A1
Нинель Григорьевна Арцимович, Татьяна Александровна Фадеева, Юлия Анатольевна Шалыминова, Татьяна Евгеньевна Захарова, Ираида Андреевна Асташина, Ольга Васильевна Щербакова, Михаил Исаевич Шмарьян, Александр Борисович Вайншток, Нина Васильевна Климова, Лидия Николаевна Лаврова, Александр Петрович Сколдинов · 1990 · SU1586711A1 · patent family 20708410
Published 1990-08-23.
Reported patent results
Reported findings
Case reports describe improved walking, ulcer healing and a lymphocyte marker, with no reliable treatment-rate estimate.
Kemantane patent describes selected clinical cases of vascular and respiratory disease without a controlled cohort.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Peripheral-vascular case | Walking distance reportedly increased from 100–150 m to 500–700 m | One patient; concurrent care and standardized testing not established · After a two-week course; one-year observation mentioned |
| Ulcer case | Foot ulcers reportedly healed during treatment | Another individual case, not a controlled ulcer-healing rate · Two weeks; favorable one-year observation described |
| Chronic-bronchitis case | E-rosette marker 12% → 50%, alongside improved symptoms | Single-patient immune-marker change · Around day 10 |
Selected cases and marker changes do not establish general immune benefit, autoimmune disease control, clinical efficacy or long-term safety.
Source for the extracted data ↗ · Checked 2026-11-06
Patent claims and provenance
Use. The Soviet publication describes Kemantane in an immunostimulatory application.
Historical disclosure is not a modern controlled clinical trial and does not establish autoimmune benefit.
- Publication
- SU1586711A1 ↗ · 1990-08-23
- Earliest priority / filing
- 1977-05-13 / 1977-05-13
- Original applicant / assignee
- Институт фармакологии АМН СССР
- Indexed status
- Not shown; official status unverified · checked 2026-11-06
- Patent family
- 20708410 · family publications are related filings, not independent studies.
Original title, inventors and related publications
Immunostimulating agent "kemantan"
Inventors: Нинель Григорьевна Арцимович; Татьяна Александровна Фадеева; Юлия Анатольевна Шалыминова; Татьяна Евгеньевна Захарова; Ираида Андреевна Асташина; Ольга Васильевна Щербакова; Михаил Исаевич Шмарьян; Александр Борисович Вайншток; Нина Васильевна Климова; Лидия Николаевна Лаврова; Александр Петрович Сколдинов.
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- Historical disclosure is not a modern controlled clinical trial and does not establish autoimmune benefit.
- Selected cases and marker changes do not establish general immune benefit, autoimmune disease control, clinical efficacy or long-term safety.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; the record gives its source-check date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original patent text and indexed metadata
Review depth: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related-report group: patent-family-20708410. Reports in this group are not assumed to be independent trials.
Source access and review scope
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Recorded source-check date: 2026-11-06. This date does not imply a completed systematic review.
Source type: Patent publication
Citation and original source
Original source: Нинель Григорьевна Арцимович, Татьяна Александровна Фадеева, Юлия Анатольевна Шалыминова, Татьяна Евгеньевна Захарова, Ираида Андреевна Асташина, Ольга Васильевна Щербакова, Михаил Исаевич Шмарьян, Александр Борисович Вайншток, Нина Васильевна Климова, Лидия Николаевна Лаврова, Александр Петрович Сколдинов. Kemantane: historical immunostimulatory-use disclosure — SU1586711A1 SU1586711A1 · patent family 20708410 1990.
Molekul research summary: https://molekul.io/research/patent-su1586711a1. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry